Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)

Completed

Conditions studied: Hyperphosphatemia

In brief

Patients who have been treated with Fosrenol for a minimum of 12 consecutive weeks and are receiving dialysis will be followed for 5 years to compare mortality, bone fractures and incidence of selected morbidities to patients with no lanthanum exposure and to patients being treated for hyperphosphatemia with any marketed product.

Key facts

Study ID
NCT00567723
Run by
Shire
People needed
2105
Starts
2006-04-25
Expected to finish
2016-06-07
Last updated by the study team
2021-03-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.